NASDAQ: CLVR | Healthcare / Drug Manufacturers / USA |
3.00 | -0.0199 | -0.66% | Vol 20.63K | 1Y Perf 387.10% |
Oct 4th, 2023 15:22 DELAYED |
BID | 2.94 | ASK | 3.01 | ||
Open | 3.06 | Previous Close | 3.02 | ||
Pre-Market | 3.18 | After-Market | - | ||
0.16 5.30% | - - |
Target Price | 2.28 | Analyst Rating | Hold 3.00 | |
Potential % | -24.25 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★★★+ 58.01 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | — - | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | -0.09 | Earnings Rating | — | |
Market Cap | 4.57M | Earnings Date | 8th Nov 2023 | |
Alpha | -0.10 | Standard Deviation | 0.31 | |
Beta | 2.30 |
Today's Price Range 2.853.08 | 52W Range 3.0225.49 |
Summary:
Neutral
Technical Indicators: | Sell |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | -13.47% | ||
1 Month | -29.77% | ||
3 Months | 1 324.53% | ||
6 Months | 741.23% | ||
1 Year | 387.10% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -78.07 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -55.13 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -58.25 | |||
Return on invested Capital Q | -24.56 | |||
Return on invested Capital Y | -35.91 | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | 1.30 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-0.20 | ||||
0.23 | ||||
1.23 | ||||
- | ||||
-0.60 | ||||
-0.94 | ||||
0.24 | ||||
1.57 | ||||
3.61M | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.70 | ||||
4.90 | ||||
0.04 | ||||
0.07 | ||||
-8.40 | ||||
Leverage Ratio | 1.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
26.40 | ||||
-343.90 | ||||
-317.30 | ||||
- | ||||
- |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
13.19M | ||||
0.30 | ||||
- | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2024 | - | -0.07 | - |
Q01 2023 | - | -0.09 | - |
Q03 2022 | - | -0.19 | - |
Q02 2022 | - | -0.20 | - |
Q01 2022 | - | -0.52 | - |
Q03 2021 | - | -0.44 | - |
Q02 2021 | - | -0.40 | - |
Q01 2021 | - | -0.36 | - |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 8th Nov 2023 |
Estimated EPS Next Report | - |
Estimates Count | - |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 20.63K |
Shares Outstanding | 1.52K |
Shares Float | 1.23M |
Trades Count | 208 |
Dollar Volume | 61.61K |
Avg. Volume | 75.19K |
Avg. Weekly Volume | 15.42K |
Avg. Monthly Volume | 59.51K |
Avg. Quarterly Volume | 150.64K |
Clever Leaves Holdings Inc. (NASDAQ: CLVR) stock closed at 3.02 per share at the end of the most recent trading day (a -3.21% change compared to the prior day closing price) with a volume of 13.74K shares and market capitalization of 4.57M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 477 people. Clever Leaves Holdings Inc. CEO is Kyle Detwiler.
The one-year performance of Clever Leaves Holdings Inc. stock is 387.1%, while year-to-date (YTD) performance is 883.71%. CLVR stock has a five-year performance of %. Its 52-week range is between 3.02 and 25.488, which gives CLVR stock a 52-week price range ratio of -0.09%
Clever Leaves Holdings Inc. currently has a PE ratio of -0.20, a price-to-book (PB) ratio of 0.23, a price-to-sale (PS) ratio of 1.23, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -55.13%, a ROC of -58.25% and a ROE of -78.07%. The company’s profit margin is -%, its EBITDA margin is -317.30%, and its revenue ttm is $13.19 Million , which makes it $0.30 revenue per share.
Of the last four earnings reports from Clever Leaves Holdings Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Clever Leaves Holdings Inc.’s next earnings report date is 08th Nov 2023.
The consensus rating of Wall Street analysts for Clever Leaves Holdings Inc. is Hold (3), with a target price of $2.28, which is -24.25% compared to the current price. The earnings rating for Clever Leaves Holdings Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Clever Leaves Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Clever Leaves Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 53.35, ATR14 : 0.36, CCI20 : -132.86, Chaikin Money Flow : -0.23, MACD : 0.24, Money Flow Index : 58.34, ROC : -20.11, RSI : 49.71, STOCH (14,3) : 0.00, STOCH RSI : 0.00, UO : 32.30, Williams %R : -100.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Clever Leaves Holdings Inc. in the last 12-months were: Andres Fajardo (Sold 183 273 shares of value $72 762 ), Gary Julien (Sold 251 shares of value $53 ), Henry Hague (Sold 24 424 shares of value $10 169 ), Henry R. Hague (Sold 14 696 shares of value $5 922 ), Julian Wilches (Sold 8 386 shares of value $3 127 ), Julien Gary M (Sold 251 shares of value $52 ), Muecke William (Sold 251 shares of value $52 ), William Muecke (Sold 251 shares of value $53 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Hold | Hold | Hold |
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States.
CEO: Kyle Detwiler
Telephone: +1 646 880-4382
Address: 489 Fifth Avenue, New York 10017, NY, US
Number of employees: 477
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.